Market Tracker

12/19 6:05pm ET

Novo Nordisk A/S (NYSE:NVO)

43.81
Data as of Dec 19
 -0.59 / -1.33%
Today’s Change
35.68
Today|||52-Week Range
49.11
+18.56%
Year-to-Date

Today’s Trading

Previous close44.40
Today’s open43.55
Day’s range43.46 - 44.02
Volume2,539,281
Average volume (3 months)1,518,360
Market cap$90.5B
Dividend yield1.90%
Data as of 4:06pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+23.61%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+10.11%
P/E ratio--
Price/Sales6.64
Price/Book14.75

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.42-0.58%
CELGCelgene+0.70+0.60%
LLYEli Lilly and Co-0.05-0.07%
BMYBristol-Myers Squibb+0.51+0.84%
Data as of 4:10pm ET, 12/19/2014

Financials

Next reporting dateJanuary 30, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$14.9B
Annual profit (last year)$4.5B
Net profit margin30.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts